The World Health Organization (WHO) has connected four cough syrups made in India to 66 infant fatalities in The Gambia.
The organisation warned consumers about four syrups on Wednesday, saying they “contain prohibited quantities of diethylene glycol and ethylene glycol as contaminants.”
“This WHO Medical Product Alert refers to four substandard products, identified in The Gambia and reported to WHO in September 2022. Substandard medical products are products that fail to meet either their quality standards or specifications and are therefore ‘out of specification,’” the report reads in part.
“The four products are Promethazine Oral Solution, Kofexmalin Baby Cough Syrup, Makoff Baby Cough Syrup and Magrip N Cold Syrup. The stated manufacturer of these products is Maiden Pharmaceuticals Limited (Haryana, India).
“To date, the stated manufacturer has not provided guarantees to WHO on the safety and quality of these products.
“If you have these substandard products, please DO NOT use them. If you, or someone you know, have used these products, or suffered any adverse reaction/event after use, you are advised to seek immediate medical advice from a qualified healthcare professional and report the incident to the National Regulatory Authority or National Pharmacovigilance Centre.”
The group added that ethylene glycol and diethylene glycol are poisonous substances that are lethal to humans when swallowed.
The four items have been located in The Gambia, however they could have traveled to other nations or areas.
The Gambia is a nation situated in West Africa, just as Nigeria.